{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-08-21T12:22:47.553148+00:00",
  "news": [
    {
      "title": "Why investors should buy Amphenol & avoid Vertex Pharmaceuticals - uk.finance.yahoo.com",
      "link": "https://news.google.com/rss/articles/CBMiigFBVV95cUxOeElCMTNzQVM5cDdZWklLNUtPZklXcm9sejhFakVDSmgzbGIwcHVtZ3dxQ2VnUFFnRW5jMFRUZkVLVDRoM241QUFxenlscEZUcHA3cy12QVM2TWNiY2ZwVHJMZng0TTRST1hDZmdUOTFLT3FTUU4tREEtanVqMENFS3QtVGEtMUtLX3c?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiigFBVV95cUxOeElCMTNzQVM5cDdZWklLNUtPZklXcm9sejhFakVDSmgzbGIwcHVtZ3dxQ2VnUFFnRW5jMFRUZkVLVDRoM241QUFxenlscEZUcHA3cy12QVM2TWNiY2ZwVHJMZng0TTRST1hDZmdUOTFLT3FTUU4tREEtanVqMENFS3QtVGEtMUtLX3c?oc=5\" target=\"_blank\">Why investors should buy Amphenol & avoid Vertex Pharmaceuticals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">uk.finance.yahoo.com</font>",
      "published": "2025-08-21T11:00:17+00:00",
      "source": "uk.finance.yahoo.com"
    },
    {
      "title": "What's Wrong With Vertex Pharmaceuticals Stock? - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMikgFBVV95cUxQV1g2UTlYQ2VFVUQybnItNDVkZTdTQ08xdlZTZjVrN2hhZkIxckEwcFd0dTQzWUxzMFdjT2tXVjdoQXhZcDczMmpiZ3B3NXptRmpLVmw5TUtMbG5XYU9SdFVkR0ZlTWZMcUs2NVphNGVQeDU4a3FiZFFnWVBqaDN0Q0M4dWZxbWVEMzFhR20tY21TZw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikgFBVV95cUxQV1g2UTlYQ2VFVUQybnItNDVkZTdTQ08xdlZTZjVrN2hhZkIxckEwcFd0dTQzWUxzMFdjT2tXVjdoQXhZcDczMmpiZ3B3NXptRmpLVmw5TUtMbG5XYU9SdFVkR0ZlTWZMcUs2NVphNGVQeDU4a3FiZFFnWVBqaDN0Q0M4dWZxbWVEMzFhR20tY21TZw?oc=5\" target=\"_blank\">What's Wrong With Vertex Pharmaceuticals Stock?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2025-08-20T08:14:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "Undercovered Dozen: BrightSpire Capital, Vertex Pharmaceuticals, Adobe And More - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPT3k5b0hjTXczM3VPY2RHYUh0TzEzV2wyQUJ1aDRmbm13eDF5MEpYQXpYaFpfYlJobk96VXpLbURZM3FtRHhoUjRzWHBlUGQ0RXgyX21lb0R1c3JpT2lfLVRjVDBDTTQxS2VONlIxekN4NFJqOFhZRXZhVGt5LTlYckZmbERObHpZdE41aGZzNWtQRlR1YXUybUgzbTJ0U1F4MDBxRjJJOUMwRU1ObnFZX3M2eDZKYzZQVXc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiugFBVV95cUxPT3k5b0hjTXczM3VPY2RHYUh0TzEzV2wyQUJ1aDRmbm13eDF5MEpYQXpYaFpfYlJobk96VXpLbURZM3FtRHhoUjRzWHBlUGQ0RXgyX21lb0R1c3JpT2lfLVRjVDBDTTQxS2VONlIxekN4NFJqOFhZRXZhVGt5LTlYckZmbERObHpZdE41aGZzNWtQRlR1YXUybUgzbTJ0U1F4MDBxRjJJOUMwRU1ObnFZX3M2eDZKYzZQVXc?oc=5\" target=\"_blank\">Undercovered Dozen: BrightSpire Capital, Vertex Pharmaceuticals, Adobe And More</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-08-18T13:01:19+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Vertex to Participate in Upcoming September 2025 Investor Conferences - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPTzN0dmdOVGRReGNHQVZLQTdhZG1wdV91S3pIUDh5VWtBOGc5Y0RHTDdyaDFHVjFOam42S05EYThpLUxMMWplQjQ0YkpUdzFtc0liTklDenJWQXpkdThCMi15TTVoX25sT2d1UWlXMEpUbVc5ekw5cHI3Y0gyXzBrWXBDNGZPeU5iX1lLRFBDOU5YX29sbVY3Sk1iOVJVNFE5NmR1Y3NMbzlGc0NQNkE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMirgFBVV95cUxPTzN0dmdOVGRReGNHQVZLQTdhZG1wdV91S3pIUDh5VWtBOGc5Y0RHTDdyaDFHVjFOam42S05EYThpLUxMMWplQjQ0YkpUdzFtc0liTklDenJWQXpkdThCMi15TTVoX25sT2d1UWlXMEpUbVc5ekw5cHI3Y0gyXzBrWXBDNGZPeU5iX1lLRFBDOU5YX29sbVY3Sk1iOVJVNFE5NmR1Y3NMbzlGc0NQNkE?oc=5\" target=\"_blank\">Vertex to Participate in Upcoming September 2025 Investor Conferences</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-08-21T06:44:19+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Vertex Pharmaceuticals: Promising Growth with Successful Launch and Strong Pipeline - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQWEN0dzJBekJiaFJYMm9qbVN5Q3djdThMV0VTSlI2aDRDSDM2ZHhCOHI5N3BxTzRMcnVRVzNBM05Sc21acGdKcXRhM01XTkdNT1QyLVRpWmFiMkJKb1lOZkxzMlBnbHFWbzAzUXdPNTBncG9ReGlkLXBMaFNIc1NRSTV1UjRxcUFmQ0RiTl9RUjJFdU9jQ0V0Si0wdW9mQ01ITWo1WVhzbUhEV253dmh4LVI0TnJvZ3BCVWNfNFFDVXowc0xvdU8w?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMixwFBVV95cUxQWEN0dzJBekJiaFJYMm9qbVN5Q3djdThMV0VTSlI2aDRDSDM2ZHhCOHI5N3BxTzRMcnVRVzNBM05Sc21acGdKcXRhM01XTkdNT1QyLVRpWmFiMkJKb1lOZkxzMlBnbHFWbzAzUXdPNTBncG9ReGlkLXBMaFNIc1NRSTV1UjRxcUFmQ0RiTl9RUjJFdU9jQ0V0Si0wdW9mQ01ITWo1WVhzbUhEV253dmh4LVI0TnJvZ3BCVWNfNFFDVXowc0xvdU8w?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: Promising Growth with Successful Launch and Strong Pipeline</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-08-18T11:55:03+00:00",
      "source": "TipRanks"
    },
    {
      "title": "Goldman Sachs Reiterated a Buy Rating on Vertex Pharmaceuticals (VRTX), Kept the PT Unchanged - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxPZkNIU0JuZWlPeHlqZ2hFREpXTmk2RDdGd250NnBOWU5lR1RCTVRxY0ZUSWRhNUpYX2JZNnBOcDA1RTdTOGhWWW1QdzJteElVQW1yb1ZQLVlhYTh3c1NjbFhuZXkyRE9TaTJueWtSTnpMaG9YT09faFdQUmpDRmtERDZGTjZhOGpa?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPZkNIU0JuZWlPeHlqZ2hFREpXTmk2RDdGd250NnBOWU5lR1RCTVRxY0ZUSWRhNUpYX2JZNnBOcDA1RTdTOGhWWW1QdzJteElVQW1yb1ZQLVlhYTh3c1NjbFhuZXkyRE9TaTJueWtSTnpMaG9YT09faFdQUmpDRmtERDZGTjZhOGpa?oc=5\" target=\"_blank\">Goldman Sachs Reiterated a Buy Rating on Vertex Pharmaceuticals (VRTX), Kept the PT Unchanged</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-19T03:19:54+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Why Vertex Pharma Is Feeling The Pain Despite A Second-Quarter Beat - Investor's Business Daily",
      "link": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPMGFNTjBhUnB5R2tQVzJIZWN2aHlJZ09Rd0VWaThnSWlOd2NKODBHWXo1ZjVVY1o2bzk0aUQtTG5MN0hMNmo4akdyT0tZZ1IwN2ZsQkZSSnJ5cWtMTmRWNGNOSVEydjc4QnZWTmdxR3ZCblhTQ0VEUXFZazdTMndnWmhuU0s2YmdEVHVxNXRFNFRnMi1ROW83MUF3bw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimwFBVV95cUxPMGFNTjBhUnB5R2tQVzJIZWN2aHlJZ09Rd0VWaThnSWlOd2NKODBHWXo1ZjVVY1o2bzk0aUQtTG5MN0hMNmo4akdyT0tZZ1IwN2ZsQkZSSnJ5cWtMTmRWNGNOSVEydjc4QnZWTmdxR3ZCblhTQ0VEUXFZazdTMndnWmhuU0s2YmdEVHVxNXRFNFRnMi1ROW83MUF3bw?oc=5\" target=\"_blank\">Why Vertex Pharma Is Feeling The Pain Despite A Second-Quarter Beat</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investor's Business Daily</font>",
      "published": "2025-08-05T07:00:00+00:00",
      "source": "Investor's Business Daily"
    },
    {
      "title": "Vertex Pharmaceutical Stock Dives as Firm to Stop Developing Acute Pain Drug - Investopedia",
      "link": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPSm1iMzM5VjEteHhaVHNhempsaUUwVmJzc3NmSlpVRnhkeWRVWmhlR2d3b0RZMzhZdXdzT28wU0FtbUczSXNoUDZCMnJPZGk5ZERFYVh4Z2RmZ3ZzOUM3QTdwc0tQdDFWR092VjIwSllxNWdpTE1OUTRxcVVKMzR4aURwZmVkdENiWHBsVi1PcGJ2cy1ab0NpUHVoN2QwdFYzYldTMnNLc2lrUEV3bm1MSlVaTG0?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMitAFBVV95cUxPSm1iMzM5VjEteHhaVHNhempsaUUwVmJzc3NmSlpVRnhkeWRVWmhlR2d3b0RZMzhZdXdzT28wU0FtbUczSXNoUDZCMnJPZGk5ZERFYVh4Z2RmZ3ZzOUM3QTdwc0tQdDFWR092VjIwSllxNWdpTE1OUTRxcVVKMzR4aURwZmVkdENiWHBsVi1PcGJ2cy1ab0NpUHVoN2QwdFYzYldTMnNLc2lrUEV3bm1MSlVaTG0?oc=5\" target=\"_blank\">Vertex Pharmaceutical Stock Dives as Firm to Stop Developing Acute Pain Drug</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investopedia</font>",
      "published": "2025-08-05T07:00:00+00:00",
      "source": "Investopedia"
    }
  ],
  "product_launches": [
    {
      "title": "Vertex Pharmaceuticals: Bullish Outlook with Strong Launch and Pipeline Growth - AInvest",
      "link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOcERyT0IwMndkcVNyYUhVaWpRYkVDMHV3cmNBenlDV1AwYXUtYUdWcndmeUt6R1g0Q19TRE13QVpKMnYxLXFFMjVkTkJzdjFwd0hLSzdCZkZYNHlXT00wSzBiSENwRVVPTlU4SFdfRno2ZU9Zc01QUVRhTVhGdWpDa0FKX3VhLU9ZNDVQczMzdDEyMFhjV3lNRnVOdjFTVFU4TkdnbVZ3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipgFBVV95cUxOcERyT0IwMndkcVNyYUhVaWpRYkVDMHV3cmNBenlDV1AwYXUtYUdWcndmeUt6R1g0Q19TRE13QVpKMnYxLXFFMjVkTkJzdjFwd0hLSzdCZkZYNHlXT00wSzBiSENwRVVPTlU4SFdfRno2ZU9Zc01QUVRhTVhGdWpDa0FKX3VhLU9ZNDVQczMzdDEyMFhjV3lNRnVOdjFTVFU4TkdnbVZ3?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: Bullish Outlook with Strong Launch and Pipeline Growth</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>",
      "published": "2025-08-20T00:36:42+00:00",
      "source": "AInvest"
    },
    {
      "title": "Vertex Pharmaceuticals: Promising Growth with Successful Launch and Strong Pipeline - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQWEN0dzJBekJiaFJYMm9qbVN5Q3djdThMV0VTSlI2aDRDSDM2ZHhCOHI5N3BxTzRMcnVRVzNBM05Sc21acGdKcXRhM01XTkdNT1QyLVRpWmFiMkJKb1lOZkxzMlBnbHFWbzAzUXdPNTBncG9ReGlkLXBMaFNIc1NRSTV1UjRxcUFmQ0RiTl9RUjJFdU9jQ0V0Si0wdW9mQ01ITWo1WVhzbUhEV253dmh4LVI0TnJvZ3BCVWNfNFFDVXowc0xvdU8w?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMixwFBVV95cUxQWEN0dzJBekJiaFJYMm9qbVN5Q3djdThMV0VTSlI2aDRDSDM2ZHhCOHI5N3BxTzRMcnVRVzNBM05Sc21acGdKcXRhM01XTkdNT1QyLVRpWmFiMkJKb1lOZkxzMlBnbHFWbzAzUXdPNTBncG9ReGlkLXBMaFNIc1NRSTV1UjRxcUFmQ0RiTl9RUjJFdU9jQ0V0Si0wdW9mQ01ITWo1WVhzbUhEV253dmh4LVI0TnJvZ3BCVWNfNFFDVXowc0xvdU8w?oc=5\" target=\"_blank\">Vertex Pharmaceuticals: Promising Growth with Successful Launch and Strong Pipeline</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-08-18T11:55:03+00:00",
      "source": "TipRanks"
    },
    {
      "title": "(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain - Vertex Pharmaceuticals Newsroom",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxQNGhZSnljSUNJSGJ4SzNPVXdNeXNncWRyT1dUWVY2VDVxWDFhamJGQUtSWlhJLVVJMmhSQjROckJNemJGZVlkY3ZmR0ZmYXBiX1J1ZHExdk1ZOW1wTWp5T1ZWa283c2RkYjdkUlgwMEtNejlNb3NJbVZJZlpyVmNweWptQ3dWeDAtV0NfVEJXNG5RU1pTZFRUY01hOEd0SXdwMXFTdEpGTnJTMklMX2NRUnBwUGhndjcyWUJzc0pn?oc=5\" target=\"_blank\">(suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals Newsroom</font>",
      "published": "2025-01-30T08:00:00+00:00",
      "source": "Vertex Pharmaceuticals Newsroom"
    },
    {
      "title": "Vertex Reports Second Quarter 2025 Financial Results - Business Wire",
      "link": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQMWJFb2Noa0FVRVkzbmRWczF1SW5EcTk5RDNFUUxILUdsYW9veGlEbnV1SkY2S0p2WFRBYV9JVFFEUkUtc3BFN1hhRk55TklJcFlOWnlIU012RlhqVnl3aU5oUHpOZ3B6TXNReExoMEl5QWRRRHBVOE9aUUJudVZzLV9qTUhOQ1hZTHlnNTNuN2ZPb2tCV056enlVR1dWVl9Lb2dldEFxcG92UklZeEE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMirgFBVV95cUxQMWJFb2Noa0FVRVkzbmRWczF1SW5EcTk5RDNFUUxILUdsYW9veGlEbnV1SkY2S0p2WFRBYV9JVFFEUkUtc3BFN1hhRk55TklJcFlOWnlIU012RlhqVnl3aU5oUHpOZ3B6TXNReExoMEl5QWRRRHBVOE9aUUJudVZzLV9qTUhOQ1hZTHlnNTNuN2ZPb2tCV056enlVR1dWVl9Lb2dldEFxcG92UklZeEE?oc=5\" target=\"_blank\">Vertex Reports Second Quarter 2025 Financial Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Business Wire</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Business Wire"
    },
    {
      "title": "Vertex, with new launches gaining steam, boosts revenue forecast despite Trikafta dilemma in Russia - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOZ0RxdG8zMm1DUDBpWlFZdk1fMlZBOTlnZi03RTBQYVlKSWRQQ3hNOEhQMUoxVXJRelFTX3RyNkk5X3RwV0IyODkwSVNXR0NHTWVpTHhBRXpvSDAxemJQTjRvWjY2aUpQMXpiNExLRXZ1dkdpY1dudE5FWm10Y1lKVzg3dHcyd2FkZ0RvdlJqSmVJTFFlRS1rbm10aWh2M2lpMnpoVWRWZXVRM1JYeXAxbm9TQ1ZhMWozMWZXY2I1REkwSlE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOZ0RxdG8zMm1DUDBpWlFZdk1fMlZBOTlnZi03RTBQYVlKSWRQQ3hNOEhQMUoxVXJRelFTX3RyNkk5X3RwV0IyODkwSVNXR0NHTWVpTHhBRXpvSDAxemJQTjRvWjY2aUpQMXpiNExLRXZ1dkdpY1dudE5FWm10Y1lKVzg3dHcyd2FkZ0RvdlJqSmVJTFFlRS1rbm10aWh2M2lpMnpoVWRWZXVRM1JYeXAxbm9TQ1ZhMWozMWZXY2I1REkwSlE?oc=5\" target=\"_blank\">Vertex, with new launches gaining steam, boosts revenue forecast despite Trikafta dilemma in Russia</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-05-06T07:00:00+00:00",
      "source": "Fierce Pharma"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-08-20",
      "close": 394.3599853515625
    },
    "history": [
      {
        "date": "2025-08-12",
        "close": 387.7699890136719
      },
      {
        "date": "2025-08-13",
        "close": 395.9200134277344
      },
      {
        "date": "2025-08-14",
        "close": 390.29998779296875
      },
      {
        "date": "2025-08-15",
        "close": 392.7900085449219
      },
      {
        "date": "2025-08-18",
        "close": 389.8800048828125
      },
      {
        "date": "2025-08-19",
        "close": 390.760009765625
      },
      {
        "date": "2025-08-20",
        "close": 394.3599853515625
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}